Perinatal Diagnosis of GIT Anomalies

NCT ID: NCT03514940

Last Updated: 2020-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

130 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-02

Study Completion Date

2020-07-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

fetal gastro intestinal abnormalities can be accurately diagnosed in second trimester

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

prenatal diagnosis of these anomalies allows for early postnatal interventions and implementation of treatment options

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fetal Anomalies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound

second trimester us scan will be made to pregnant women

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant women either primi or multigravida
* pregnant in 18- 24 weeks

Exclusion Criteria

* first trimester pregnant ladies
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role collaborator

National Research Centre, Egypt

OTHER

Sponsor Role collaborator

Aljazeera Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Alalfy

Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahmoud Alalfy, M.s.c

Role: PRINCIPAL_INVESTIGATOR

Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Algazeerah

Giza, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahmoud Alalfy

Role: CONTACT

01002611058

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mahmoud Alalfy, master

Role: primary

+201002611058

Ahmed Elgazzar, M.D

Role: backup

+201014005959

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GIT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Accuracy of Rail Sign at Detection of PAS
NCT07159997 NOT_YET_RECRUITING NA